Class & Mechanism
FOXO4-DRI is a senolytic peptide that disrupts the interaction between p53 and FOXO4, thereby selectively inducing the death of senescent cells. Senescent cells are those that have lost their ability to divide and function properly, and their accumulation is associated with aging and age-related diseases. By targeting and eliminating these cells, FOXO4-DRI aims to reduce cellular senescence and its associated negative effects [37].
Research-documented benefits
Local corpus: silent.
General-knowledge benefits
FOXO4-DRI has been studied for its potential to delay aging and treat age-related diseases by selectively eliminating senescent cells. Preclinical studies have shown that treatment with FOXO4-DRI can reduce markers of cellular senescence, improve tissue function, and extend healthspan in animal models [37]. Additionally, senolytic therapies like FOXO4-DRI have been investigated for their potential to treat conditions such as osteoarthritis, atherosclerosis, and cancer by targeting the senescent cells that contribute to these diseases [37].
Typical injectable protocol
The typical injectable protocol for FOXO4-DRI is not well-established in the literature. However, based on its use in preclinical studies, it is generally administered subcutaneously (SC) or intravenously (IV) in the range of micrograms (µg) per dose, with treatment cycles varying depending on the specific condition being treated and the individual's response to therapy.
Key risks / contraindications
As with any peptide therapy, FOXO4-DRI carries a risk of allergic reactions or anaphylaxis. It should not be used in patients with a known hypersensitivity to the peptide or any of its components. Additionally, its safety in pregnant or breastfeeding women is not well-established.
Bottom line
FOXO4-DRI is a senolytic peptide with potential therapeutic benefits in delaying aging and treating age-related diseases by selectively eliminating senescent cells. Its use is primarily investigational, and further research is needed to fully understand its mechanisms and establish its safety and efficacy profile.
References
- Adenoviruses_ Basic Biology to Gene Therapy
- Advances in drug delivery
- Antioxidants and redox signaling_ impact on NF-κB and Nrf2
- Antisense Research and Application
- Antisense oligonucleotides_ the state of the art
- Biomaterials Science_ An Introduction to Materials in Medicine
- Cancer_ Principles & Practice of Oncology
- Cells, Aging, and Human Disease
- Chemical Biology of Nucleic Acids
- Gene Therapy_ Therapeutic Mechanisms and Strategies
- Gene and Cell Therapy_ Therapeutic Mechanisms and Strategies
- Inclisiran in patients at high cardiovascular risk
- Medicinal Chemistry of Anticancer Drugs
- Mitochondrial Medicine_ Volume II, Manipulating Mitochondrial Function
- Oxidative Stress and Inflammation in Non-communicable Diseases_ Molecular Mechanisms and Perspectives in Therapeutics
- Peptide Bioregulators in Gerontology
- Peptide Therapeutics_ Design and Development
- Peptides and Non Peptides of Oncologic and Endocrine Interest
- Peptides_ Chemistry and Biology, 2nd Edition
- Pharmacology
- Principles and Practice of the Biologic Therapy of Cancer
- Prodrugs_ Challenges and Rewards
- RNA Interference Technology
- RNA Interference_ From Biology to Clinical Applications
- RNA Therapeutics_ Function, Design, and Delivery
- Sirtuins and NAD br sup + sup br
- The Metabolic Role of Phosphate